Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

GLOBAL PHARMACOVIGILANCE-2020

About Conference


Conference Series llc LTD warmly invites all the participants across the world to “14th Global Pharmacovigilance & Clinical Trail Summit” scheduled on February 12-13, 2020 Sydney, Australia. This conference provides a forum for interaction among attendees with discussion involving discovery of a new drug, Challenges in drug development, Pre-Clinical and Clinical trial reports, Case Studies, Pharmacovigilance, Biosimilar and Bio logistics and its eye on new drug regulatory approvals. Session discussions focus on discussions about approaches and innovations for Patient Benefit Risk Management in Pharma, Biotech and Health care Industry.

This is a 2 day Mega Event offering Exhibition, at venue to showcase the new and emerging technologies with Keynote presentation, Oral talks, Poster presentations and Exhibitions.

Why to Attend???

To meet your targeted audience in the Series of Pharmacovigilance 2020 Conference with a largest assemblage of participants from the Pharma, Clinical, Healthcare and Regulatory community providing an international and non-biased platform for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area alarming on Medication Safety.

It is an Unique Opportunity for Advertisers and Sponsors at this International event.

Who to attend???

Pharmacovigilance Students, Scientists
Pharmacovigilance Researchers & Teachers
Medical Colleges
Pharmaceutical Industries
Pharmacovigilance Associations and Societies
Pharmacovigilance Training Institutes
Software Developing Companies
Medical Devices Manufacturing Companies
Data Management Companies
Business Entrepreneurs

Also, Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of:

CROs and CMOs
Clinical Research Sites
Pharma/Biotech and Medical Device industries
Hospitals, Associations

University Faculties scientists who are related to clinical and medical research like

Directors
Senior Professors
Assistant Professors
Associate Professor
Research Scholars
Ph.D Students

 

Session / Tracks

Track 1: Pharmacovigilance and Clinical Trials

Pharmacovigilance and Clinical Trials will have the fast development of new drug and innovative therapeutics, new pharmacovigilance actions and methods have to be implemented for assurance and Patient Benefit Safety Management in Pharma, Biotech and Health Care. Clinical Trails contain the best quality level to calculate the viability and wellbeing of new medications. However, in light of the fact that they are directed in homogeneous conditions a long way from this present reality of solution and use, errors in patient choice or treatment situations may change both the viability and risks.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and EffectivenessInternational Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences | Pharmacovigilance Sydney | Pharmacovigilance Australia 2020 |  Pharmacovigilance  Sydney 2020 | International Pharmacovigilance sydney Australia | pharmacovigilance  and clinical trials 2020 | Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit

 

Track 2:  Pharmacovigilance Practice

The piece of Good Pharmacovigilance Practice and Pharmaco-epidemiology in Risk Management is widely to manufacture the probability of productive effects of a drug in a people than the probability of antagonistic effects and to keep up the Good Reporting Practices by evading the important matters in peril organization. Moreover, it is basic to center around Signal examination by party the truths on new or cloud solution influences that is possibly produced by a medicine and that finally should incite ensuring prosperity. The pharmacovigilance and clinical preliminaries organizations generous associations should have the Pharmacovigilance validation.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences | Pharmacovigilance congress 2020 | Global Pharmacovigilance 2020 conference | Global Pharmacovigilance 2020 Conference | Global Pharmacovigilance 2020 summit | Global Pharmacovigilance 2020 Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference | Global Pharmacovigilance 2020 sydney | Global Pharmacovigilance sydney Australia | Global pharmacovigilance  and clinical trials 2020 | Global Clinical Trials summit |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit

 

Track 3: Clinical Trials Pharmacovigilance

A clinical preliminary includes the testing of additional medication (or other treatment) to gauge whether it is influential and safe. Clinical preliminaries of medications can be divided into those surveying the treatment of the sickness (for example asthma) or those assessing medications to counteract the happening of huge medicinal services events later on (for example stroke). Clinical preliminaries take the quantitative data around the advantages, antagonistic influences and potential services of new medicates that license prescribers and patients to settle on sound choices with respect to tranquilize treatment.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences | | Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit

 

Track 4: Adverse Drug Reactions

We rapid associate adverse drug reaction as “an noticeably damaging or unfriendly reaction, subsequent from associate interference associated with the service of a healthful product that forecasts hazard from future administration and warrants bar or exact treatment or change of the dose plan, or extraction of the merchandise.” Such responses are presently reportable by use of WHO's Adverse Reaction nomenclature, which is able to ultimately become a set of the International Classification of Diseases.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences

 

Track 5: Causality Assessment

Causality assessment of ADRs may be a technique used for estimating the strength of relationship between drug(s) exposure and incidence of adverse reaction(s). Relation assessment of ADRs is also undertaken by clinicians, academics, the pharmaceutical trade and regulators, and in numerous settings, as well as clinical trials. At a private level, health-care suppliers assess relation informally once managing ADRs in patients to create choices concerning future medical aid. Numerous regulative authorities measure spontaneous ADR reports, wherever relation assessment will simplify in detection and risk–benefit choices concerning medicines, abuse formal CATs to help throughout this method.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences

 

Track 6: Drug Safety

The drug safety thought has reached plenty of attention during the past period cheers to the very fact it plays a important role in patients’ health. Current laws stress this idea must to be enclosed within the method of latest medications’ support and continued conduct of post-marketing drug evaluations. Benefit–risk assessment ought to be supposed of by all health care professionals when they ought to offer exact medicine to detailed teams of patients. Consequently, additional care ought to slope to some patients, like pregnant girls, youngsters and therefore the aged, meanwhile they're thought of susceptible populations.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences |

 

Track 7: Clinical Trial Protocols

All uneven clinical trials (RCTs) must a protocol; but, numerous studies have tinted protocol deficiencies. Reportage pointers might advance the content of analysis reports and, if developed mistreatment sturdy ways, might increase the utility of reports to stakeholders. The mark of this study was to reliably found and review RCT protocol pointers, to appraise their characteristics and ways of development, and to check references.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences |

 

Track 8: Clinical Research and Statistics

Clinical analysis comprises exploring deliberate medical treatments, evaluating the relative advantages of good therapies, and beginning optimum treatment combos. Clinical analysis makes an attempt to answer queries like “should a person with glandular carcinoma endure radical ablation or radiation or wait and see?” Statistics play a awfully important role in any run from style, conduct, analysis and reportage in terms of dominant for and minimizing biases, contradictory factors, and mensuration irregular errors. A grasp of applied math strategies is crucial to understanding randomized trial strategies and results.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences

 

Track 9: Clinical Database Management

The field of clinical knowledge management (CDM) has established itself cheers to demands from every the pharmaceutical business and therefore the preventive authorities. Meanwhile the inventiveness to “fast-track” the period of pharmaceutical product stands to hasten, preventive entities have responded by requiring quality-assurance values be met in accumulating the info employed in the drug analysis system. Clinical knowledge management systems (CDMS) area unit mainly important in trials conducted across medical centers throughout which a colossal quantity of information is made.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit

 

Track 10: Analysis of Data Quality and Management

Pharmacovigilance depends on data collected from the collecting of separate case safety reports and dissimilar pharmacoepidemiological information. Even given the vital limits of impulsive reports, the excellence of this information supply will be better with smart information quality management. Though under-reporting cannot be remedied this manner, the negative impact of incomplete reports, that is another significant issue in pharmacovigilance, will be reduced. Quality management consists of quality designing, internal control, quality assurance and quality enhancements. The pharmacovigilance processing cycle starts with material variety and in computerized systems, information entry; following step is information storage and maintenance; followed by information choice, retrieval and operation. The ensuing information output is analysed and assessed. Finally, conclusions square measure drawn and selections created.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit | Risk Management Conferences | Regulatory Affairs Conferences

 

Track 11: Biopharmaceutics

Biopharmaceuticals square amount vital treatment choices for a spread of chronic and characteristically critical diseases. Likened with the normal minute molecule medicine, biopharmaceuticals have exact options, which can conjointly effect their safety profile. They have, as an example, a posh production technique, restricted sure thing of analyzing to clinical knowledge, a high possible for immunogenicity, related adverse events will usually be related with an overstated medical specialty.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences

 

Track 12: Regulatory Affairs

Regulatory Affairs (RA), likewise known as government difficulties, square amount a business privileged managed enterprises, for case, set drugs, healthy gadgets, liveliness, good cash, medium so on. Body Affairs similarly encompasses a bound position within the human services enterprises (pharmaceuticals, therapeutic gadgets, biologics and cooperative nourishments). Body problems (therapeutic issues) specialists (otherwise called body experts) usually have duty regarding the related to general territories.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance 2020 | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences

 

Track 13:  Pharmacovigilance Significance and Scope

Pharmacovigilance key goal is to carry clear information concerning drug safety and its Risk or compensations of medicine to the patients. Patients are chief finish operators of medication. Patient information leaflet with reference to medication to be providing to the patient to spread the welfares of the medication and to scale back the casual related to them. It's vital for Risk reduction by creating associate early discovery and preventing the development of the adverse effects. Whole info of inadvertent and severe adverse events may well be discovery through the Pharmacovigilance. It couldn't be done through clinical trials that are lead in associate in vivo methodology.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences | Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance congress | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit

        

Track 14: Drug related problems in healthcare

A drug-related Problem (DRP) is an occasion or condition regarding drug medical aid that actually or perhaps inhibits with anticipated health results  Drug medical aid matters area unit the clinical domain of the pharmaceutical care practician. The aim of individual drug medical aid subjects is to contribution patients reach their goals of medical aid and know the most effective potential results from drug medical aid within the next sections, and to discuss the nomenclature, components, and classes of drug medical aid subjects and their central position to the smear of pharmaceutical care and medicine management services. 

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences | Drug medical aid conference sydney |Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance congress | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit        

 

Track 15: Entrepreneurs Investment Meet

A platform directed to attach Entrepreneurs, Investors, and Proposers globally. It's predictable to brand and ease industrial delegates, analysis scientists, business delegate a likely gathering for contributing persons and it might be a decent likelihood for Startup Company representatives in international business deliberations, analysis and implementation of auspicious business ideas. For entrepreneurs, it might be a perfect place to seek out appropriate investors and partners to start out and/or expand their business.

Related Societies and Associations:

International Society for Pharmacoepidemiology | Center for Drug Safety and Effectiveness |  International Pharmaceutical Federation | International Society of Pharmacovigilance | Society for Clinical Trials | Association of Clinical Research | The Society of Clinical Research Associates | Clinical Research Society | American Association of Pharmaceutical Scientists | Association of British Pharmaceutical Industry | International Pharmaceutical Federation | Pharmaceutical Society of Australia | International Pharmaceutical Federation

Related Conferences:

Pharmacovigilance Conferences | Global Pharmacovigilance Conferences | Clinical Trials Conference | Drug Safety Conference | Clinical Case Reports Conferences | Case reports Conference | Clinical development Conferences | Drug Research Conferences | Good clinical practice Conferences | Good pharmacovigilance practices Conferences | Pharmacovigilance and Risk Management Conferences | Risk Management Conferences | Regulatory Affairs Conferences | Clinical Trials summit | Pharmacovigilance congress | Pharmacovigilance conference | Pharmacovigilance  Conference | Global Pharmacovigilance  summit | Global Pharmacovigilance  Sydney Australia Summit | Global Pharmacovigilance congress | Sydney global pharmacovigilance conference |Clinical Trilas summit | Post marketing clinical trials summit | Drug medical aid conference sydney

 

Market Analysis

Global Pharmacovigilance 2020 welcomes attendees, presenters, and exhibitors from all over the world to Sydney, Australia. We are delighted to invite you all to attend and register for the “14th Global Pharmacovigilance & Clinical trials ” which is going to be held during february 12-13, 2020 sydney, Australia. The Organizing Committee is gearing up for an thrilling and informative conference program with plenary talks, symposia, workshops on a variety of topics, poster presentations and many programs for members from all over the world. We invite you to join us at the Global Pharmacovigilance 2020, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Global Pharmacovigilance 2020 Organizing Committee will look forward to meet you at Sydney, Australia.

This market is facing a significant improvement owing to patent expiration of branded drugs and increasing number of new drug expansions. This has attracted several local and international pharmacovigilance service providers. Presence of modest environment has ran to improved clinical data management, pharmacovigilance and streamlined R&D process.

The global pharmacovigilance (PV) and drug safety package market is anticipated to succeed in US$ 262.02 Mn in 2027 from US$ 151.07 Mn in 2018. The pharmacovigilance (PV) and drug safety package market is calculable to grow with a CAGR of 6.4% from 2019-2027.

Scope & Importance

Concept of Pharmacovigilance and its Significance enhances the impact of pharmacovigilance on patient welfare and public health and to understand what's pharmacovigilance. This track offers a quick discussion on Pharmacovigilance role in healthcare system. Pharmacovigilance legislation offers associate degree outlook on the principles and laws to follow in Pharmacovigilance practice. The Role of company industries within the improvement of pharmacovigilance system is extremely crucial to keep up the security information, Detection and analysis of drug safety signals through manual and medical devices coverage. Pharmacovigilance scope additionally deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in seasoning medicines.

 

Past Conference Report

Pharmacovigilance 2019

Past Conference Report

Pharmacovigilance 2019 Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Pharmacovigilance 2019 Conference the best ever!

The 12th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, hosted by the Conference Series llc LTD was held during July 04-05, 2019 at Barcelo Valencia, Av. de Franca, 11, 46023 Valencia, Spain, Valencia Spain based on the theme Exploring Latest Trends in Pharmacovigilance and Clinical Trials". Benevolent response and active participation were received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Pharmaceutics and Drug Delivery Systems, who made this event a grand success.

Conference Series expresses its gratitude to the conference Moderator, namely Deepa Arora, CLINEXEL Life Sciences Pvt Ltd, India for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Similarly, we also extend our appreciation towards our Chair Person namely, Stanley Cohan, Georgetown University School of Medicine, USA.

The conference was initiated with the Honorable presence of the Keynote forum. The list includes:

  • Stanley Cohan, Georgetown University School of Medicine, USA
  • Thierry Douki, SyMMES - INAC CEA, France

Then it was followed by the following Speakers:

  • Whitney Shatz, Genentech Inc., USA
  • Deepa Arora, CLINEXEL Life Sciences Pvt Ltd, India
  • Sunil D Nighot, Johnson & Johnson Pvt Ltd, India
  • Vishakha Oza, Grünenthal GmbH, Germany
  • Amalia Levy, Ben-Gurion University, Israel
  • Sheela Ankolekar, Norgine, UK
  • Omar Aimer, Canada
  • Thierry Douki, SYMMES - INAC CEA, France

Conference series offers its heartfelt appreciation to organizations such as our esteemed Media Partners, Exhibitors, and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. It also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Co-chairs who supported this event.

With the grand success of Pharmacovigilance 2019, Conference Series is proud to announce the "14th Global Pharmacovigilance and Clinical Trials Summit" to be held during February 12-13, 2020.

See you next year at Sydney, Australia

For More details visit: https://globalpharmacovigilance.pharmaceuticalconferences.com

 

 


Past Reports  Gallery  

Global Pharmacovigilance 2018

Pharmacovigilance 2018 Report:

We gratefully thank all our wonderful Keynote and Plenary Speakers, Conference Attendees, Students, Media Partners and Associations for making Pharmacovigilance and Drug Safety 2018 grand success.

The 11th International Conference and Exhibition on Pharmacovigilance & Drug Safety hosted by the Conference series was held during June 21-22, 2018 at London, UK based on the theme  “Global Pharmacovigilance Approaches and Innovations for Patient Benefit Risk Management". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from the area of Pharmacovigilance, Drug Safety and, Clinical Trials who made this event a grand success.

Conference series expresses its feeling to the conference Moderator, specifically Eliana silva de Moraes, Food and Drug Law, From Brazil, for seizing the responsibility to coordinate throughout the sessions. we have a tendency to area unit indebted to your support.       

Conference series would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Pharmacovigilance 2018:

  • Essam Ghanem, Celyad Biopharmaceutical, Belgium
  • Maria Amparo Lopez Ruiz, Cardenal Herrera University, Spain
  • Aaron Damien Barzey, ADB Medical, UK
  • Subodh Bhardwaj, New York & Inventprise, USA
  • Eliana Silva de Moraes, Food and Drug Law, Brazil
  • Cristina Scavone, University of Campania Luigi Vanvitelli, Italy
  • Kety Mirkovic Kos, PharmaKos d.o.o., Croatia
  • Meital Simhi, Ben Gurion University of the Negev, Israel
  • Mervat Alsous, Applied Science Private University, Jordan
  • Jyoti B Sharma, Tata Memorial Centre, India
  • Raymond R Mattingly, Wayne State University School of Medicine, USA

Conference series offers its heartfelt appreciation to organizations such as our esteemed Media Partners, Exhibitors, and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. It also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Co-chairs who supported this event.

With the grand success of Pharmacovigilance 2018, Conference series is proud to announce the " 12th International Conference and Exhibition on Pharmacovigilance & Drug Safety" to be held during July 18-19 at Rome, Italy

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date February 12-13, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Pharmaceutical Regulatory Affairs: Open Access Research & Reviews: Journal of Pharmacy and Pharmaceutical Sciences Journal of Biomedical and Pharmaceutical Sciences

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Adverse Drug Reaction (ADR)
  • Adverse Event (AE)
  • Adverse Event Of Special Interest (AESI)
  • Benefit-risk Analysis
  • Case Control Studies
  • Case Reports
  • Case Series
  • Causality Assessment
  • Clinical Development Programme
  • Clinical Trial/study
  • Cohort Studies
  • Company Core Data Sheet (CCDS)
  • Company Core Safety Information (CCSI)
  • Cross-sectional Studies
  • Data Monitoring Committee
  • Descriptive Studies
  • Development Core Safety Information (DCSI)
  • Development Pharmacovigilance And Risk Management Plan
  • Development Safety Update Report (DSUR)
  • Drug Utilization Research
  • Ecological Studies
  • Expected Adverse Drug Reaction
  • Good Clinical Practice (GCP)
  • Good Pharmacovigilance Practice
  • Harm (synonymous With Adverse Drug Reaction)
  • Hazard
  • Identified Risk
  • Important Identified Risk, Important Potential Risk
  • Individual Case Safety Report (ICSR)
  • Investigational Product
  • Investigator Brochure (IB)
  • Labelled Or Unlabelled
  • Medication Errors
  • Minimum Criteria For Reporting
  • Missing Information
  • Near-misses
  • Number Needed To Harm (NNH)
  • Observational Study
  • Periodic Safety Update Report (PSUR)
  • Pharmacoepidemiology
  • Pharmacovigilance
  • Pharmacovigilance System
  • Post-authorisation Safety Study (PASS)
  • Postmarketing Surveillance
  • Potential Risk
  • Randomised Controlled Trial (RCT)
  • Reference Safety Information (RSI)
  • Registry
  • Risk
  • Risk Management
  • Risk Management Plan
  • Risk Management System
  • Risk Minimisation Activity (used Synonymously With Risk Minimisation Measure)
  • Risk-benefit Balance
  • Safety
  • Safety Concern
  • Safety Specification
  • Serious Adverse Event (SAE)
  • Side Effect
  • Signal
  • Signal Management Process
  • Signal Validation
  • Solicited Reports
  • Sponsor
  • Spontaneous Report Or Spontaneous Notification
  • Stimulated Reporting
  • Summary Of Product Characteristics (SmPC Or SPC)
  • Suspected Unexpected Serious Adverse Reaction (SUSAR)
  • Target Population (treatment)
  • Target Population (vaccine); Synonym: Vaccine Target Population
  • Tolerability
  • Type A Adverse Drug Reaction (augmented)
  • Type B Adverse Drug Reaction (bizarre)
  • Type C Adverse Drug Reaction (chronic)
  • Type D Adverse Drug Reaction (delayed)
  • Type E Adverse Drug Reaction (end Of Use)
  • Type F Adverse Drug Reaction (failure)
  • Unexpected Adverse Drug Reaction
  • Validated Signal